172 related articles for article (PubMed ID: 21080675)
1. Synthesis of a single-molecule L-rhamnose-containing three-component vaccine and evaluation of antigenicity in the presence of anti-L-rhamnose antibodies.
Sarkar S; Lombardo SA; Herner DN; Talan RS; Wall KA; Sucheck SJ
J Am Chem Soc; 2010 Dec; 132(48):17236-46. PubMed ID: 21080675
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and immunological evaluation of a MUC1 glycopeptide incorporated into l-rhamnose displaying liposomes.
Sarkar S; Salyer AC; Wall KA; Sucheck SJ
Bioconjug Chem; 2013 Mar; 24(3):363-75. PubMed ID: 23444835
[TBL] [Abstract][Full Text] [Related]
3. Augmenting Vaccine Immunogenicity through the Use of Natural Human Anti-rhamnose Antibodies.
Hossain MK; Vartak A; Karmakar P; Sucheck SJ; Wall KA
ACS Chem Biol; 2018 Aug; 13(8):2130-2142. PubMed ID: 29916701
[TBL] [Abstract][Full Text] [Related]
4. L-rhamnose antigen: a promising alternative to α-gal for cancer immunotherapies.
Chen W; Gu L; Zhang W; Motari E; Cai L; Styslinger TJ; Wang PG
ACS Chem Biol; 2011 Feb; 6(2):185-91. PubMed ID: 21043478
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of a Liposomal MUC1 Glycopeptide-Based Immunotherapeutic and Evaluation of the Effect of l-Rhamnose Targeting on Cellular Immune Responses.
Karmakar P; Lee K; Sarkar S; Wall KA; Sucheck SJ
Bioconjug Chem; 2016 Jan; 27(1):110-20. PubMed ID: 26595674
[TBL] [Abstract][Full Text] [Related]
6. A protective vaccine delivery system for in vivo T cell stimulation using nanoengineered polymer hydrogel capsules.
Sexton A; Whitney PG; Chong SF; Zelikin AN; Johnston AP; De Rose R; Brooks AG; Caruso F; Kent SJ
ACS Nano; 2009 Nov; 3(11):3391-400. PubMed ID: 19824668
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of α-L-rhamnosyl ceramide and evaluation of its binding with anti-rhamnose antibodies.
Long DE; Karmakar P; Wall KA; Sucheck SJ
Bioorg Med Chem; 2014 Oct; 22(19):5279-89. PubMed ID: 25172148
[TBL] [Abstract][Full Text] [Related]
8. A universal T cell epitope-containing peptide from hepatitis B surface antigen can enhance antibody specific for HIV gp120.
Greenstein JL; Schad VC; Goodwin WH; Brauer AB; Bollinger BK; Chin RD; Kuo MC
J Immunol; 1992 Jun; 148(12):3970-7. PubMed ID: 1376346
[TBL] [Abstract][Full Text] [Related]
9. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
Kaumaya PT; Kobs-Conrad S; Seo YH; Lee H; VanBuskirk AM; Feng N; Sheridan JF; Stevens V
J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238
[TBL] [Abstract][Full Text] [Related]
10. Hybrid hepatitis B virus core antigen as a vaccine carrier moiety: I. presentation of foreign epitopes.
Schödel F; Peterson D; Hughes J; Wirtz R; Milich D
J Biotechnol; 1996 Jan; 44(1-3):91-6. PubMed ID: 8717391
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and Immunological Evaluation of a Single Molecular Construct MUC1 Vaccine Containing l-Rhamnose Repeating Units.
Hossain MK; Vartak A; Sucheck SJ; Wall KA
Molecules; 2020 Jul; 25(14):. PubMed ID: 32659971
[TBL] [Abstract][Full Text] [Related]
12. Chemoselective assembly and immunological evaluation of multiepitopic glycoconjugates bearing clustered Tn antigen as synthetic anticancer vaccines.
Grigalevicius S; Chierici S; Renaudet O; Lo-Man R; Dériaud E; Leclerc C; Dumy P
Bioconjug Chem; 2005; 16(5):1149-59. PubMed ID: 16173792
[TBL] [Abstract][Full Text] [Related]
13. GD3 vaccines for melanoma: superior immunogenicity of keyhole limpet hemocyanin conjugate vaccines.
Helling F; Shang A; Calves M; Zhang S; Ren S; Yu RK; Oettgen HF; Livingston PO
Cancer Res; 1994 Jan; 54(1):197-203. PubMed ID: 8261439
[TBL] [Abstract][Full Text] [Related]
14. Liposomal Fc Domain Conjugated to a Cancer Vaccine Enhances Both Humoral and Cellular Immunity.
Hossain MK; Vartak A; Sucheck SJ; Wall KA
ACS Omega; 2019 Mar; 4(3):5204-5208. PubMed ID: 30949616
[TBL] [Abstract][Full Text] [Related]
15. Rhamnose modified bovine serum albumin as a carrier protein promotes the immune response against sTn antigen.
Lin H; Hong H; Wang J; Li C; Zhou Z; Wu Z
Chem Commun (Camb); 2020 Nov; 56(90):13959-13962. PubMed ID: 33079080
[TBL] [Abstract][Full Text] [Related]
16. Fully synthetic carbohydrate-based vaccines in biochemically relapsed prostate cancer: clinical trial results with alpha-N-acetylgalactosamine-O-serine/threonine conjugate vaccine.
Slovin SF; Ragupathi G; Musselli C; Olkiewicz K; Verbel D; Kuduk SD; Schwarz JB; Sames D; Danishefsky S; Livingston PO; Scher HI
J Clin Oncol; 2003 Dec; 21(23):4292-8. PubMed ID: 14645418
[TBL] [Abstract][Full Text] [Related]
17. Preparation and characterization of monoclonal antibodies directed to the tumor-associated O-linked sialosyl-2----6 alpha-N-acetylgalactosaminyl (sialosyl-Tn) epitope.
Kjeldsen T; Clausen H; Hirohashi S; Ogawa T; Iijima H; Hakomori S
Cancer Res; 1988 Apr; 48(8):2214-20. PubMed ID: 2450649
[TBL] [Abstract][Full Text] [Related]
18. L-Rhamnose Enhances the Immunogenicity of Melanoma-Associated Antigen A3 for Stimulating Antitumor Immune Responses.
Zhang H; Wang B; Ma Z; Wei M; Liu J; Li D; Zhang H; Wang PG; Chen M
Bioconjug Chem; 2016 Apr; 27(4):1112-8. PubMed ID: 26978574
[TBL] [Abstract][Full Text] [Related]
19. Primary T-cell and activated macrophage response associated with tumor protection using peptide/poly-N-acetyl glucosamine vaccination.
Maitre N; Brown JM; Demcheva M; Kelley JR; Lockett MA; Vournakis J; Cole DJ
Clin Cancer Res; 1999 May; 5(5):1173-82. PubMed ID: 10353754
[TBL] [Abstract][Full Text] [Related]
20. A fully synthetic therapeutic vaccine candidate targeting carcinoma-associated Tn carbohydrate antigen induces tumor-specific antibodies in nonhuman primates.
Lo-Man R; Vichier-Guerre S; Perraut R; Dériaud E; Huteau V; BenMohamed L; Diop OM; Livingston PO; Bay S; Leclerc C
Cancer Res; 2004 Jul; 64(14):4987-94. PubMed ID: 15256473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
